FDA approves Pediarix to cut six shots for babies
The FDA gave approval to Pediarix, a combination vaccine that protects against diphtheria tetanus pertussis hepatitis B and polio with three injections by age six months, reducing the typical 20 injections many babies receive by age two. GlaxoSmithKline will market the vaccine early next month at roughly the same cost as the separate shots, though it does not cover meningitis or pneumonia.
MENTIONED IN THIS ARTICLE
FDA
Washington
Pediarix
Food and Drug Administration
GlaxoSmithKline
Mark M. Blatter
Primary Physicians Research
Pittsburgh
Stress management through diet and lifestyle guidance
TIM OBRIEN outlines a program to reduce stress with balanced macronutrient intake, regular aerobic exercise, diaphragmatic breathing, and adequate sleep. He emphasizes personal responsibility, optimism, and a structured routine, inviting readers to contact him for further courses and seminars.
MENTIONED IN THIS ARTICLE
Tim O'Brien
Wellington Circle East
Tallahassee
Fla
Also Mentioned on This Page
Horizon Inn & Conference Center
E. Main Carbondale
Santa
UPS
FedEx U.S. Mail
Aioe
Mardale
Sun
Cynthia Fraed
Marsha Meiners
Ecul
Ngi
Is iSmears Evaluation & Treatment
Sindenum RS
Ent
Nicole
Ntia
Passhvac
Pass
Mychoice
Marion
Carbondale
CSG
Fda.gov
Glaxo
Gsk.com
Barry Sears
United States
Ame
Southern Illinoisan
Illinois Ave
Ced